Review
doi: 10.1007/BF00254079.
Physiologically based pharmacokinetic models for anticancer drugs
- PMID: 93986
- DOI: 10.1007/BF00254079
Item in Clipboard
Review
Physiologically based pharmacokinetic models for anticancer drugs
Cancer Chemother Pharmacol.
1979.
Abstract
The rationale and history of the development of physiologically based pharmacokinetic models are briefly reviewed in this paper. The methods of model construction and the previous application of this type of model to anticancer drugs are discussed. Future research should be focused on the following areas: (1) interspecies scaling, (2) the effects of disease states on the pharmacokinetics of anticancer drugs, and (3) the applications of pharmocokinetics to the studies of growth behavior of cancer cells. The ultimate goal will be to utilize this basic information to design an optimal dosage regimen and treatment schedule for the safe and effective cancer chemotherapy of each individual patient.
Similar articles
-
Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet. 1983 May-Jun;8(3):202-32. doi: 10.2165/00003088-198308030-00002. Clin Pharmacokinet. 1983. PMID: 6189661 Review.
-
[Pharmacokinetics of antineoplastic agents (author's transl)].Bull Cancer. 1979;66(1):39-42. Bull Cancer. 1979. PMID: 311229 French.
-
Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs.Cancer Treat Rev. 1982 Jun;9(2):85-124. doi: 10.1016/s0305-7372(82)80012-1. Cancer Treat Rev. 1982. PMID: 6181872 Review. No abstract available.
-
Pharmacokinetic drug interactions of commonly used anticancer drugs.Clin Pharmacokinet. 1986 May-Jun;11(3):223-35. doi: 10.2165/00003088-198611030-00004. Clin Pharmacokinet. 1986. PMID: 2426030 Review.
-
Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine.J Pharm Sci. 1984 Jun;73(6):728-32. doi: 10.1002/jps.2600730606. J Pharm Sci. 1984. PMID: 6204036
Cited by
-
Absorption and distribution of xenobiotics.Environ Health Perspect. 1988 Apr;77:63-71. doi: 10.1289/ehp.887763. Environ Health Perspect. 1988. PMID: 3289909 Free PMC article. Review.
-
Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.J Pharmacokinet Biopharm. 1985 Aug;13(4):425-40. doi: 10.1007/BF01061478. J Pharmacokinet Biopharm. 1985. PMID: 4087170
-
ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application.Toxicol Sci. 2023 Oct 30;196(1):1-15. doi: 10.1093/toxsci/kfad081. Toxicol Sci. 2023. PMID: 37584694 Free PMC article.
-
Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development.J Biomed Biotechnol. 2011;2011:907461. doi: 10.1155/2011/907461. Epub 2011 Jun 1. J Biomed Biotechnol. 2011. PMID: 21716673 Free PMC article. Review.
-
Phase I trials in clinical oncostatic pharmacology.Cancer Chemother Pharmacol. 1980;4(1):1-3. doi: 10.1007/BF00255450. Cancer Chemother Pharmacol. 1980. PMID: 6767562 No abstract available.